VISEN Pharmaceuticals (02561.HK)株価、チャート、ニュース、およびAI分析

Q: VISEN PHARMA-B の株価パフォーマンスは？

VISEN PHARMA-B の現在の価格は $33.8 で、最終取引日から 1.51% 減少 変動しました。

Q: VISEN Pharmaceuticals の主な事業テーマや業界は？

VISEN Pharmaceuticals は Biotechnology 業界、セクターは Health Care に属しています。

Q: VISEN Pharmaceuticals の時価総額はいくらですか？

VISEN Pharmaceuticals の現在の時価総額は $3.8B です。

ホーム

株式

02561.HK

VISEN PHARMA-B (02561.HK)

VISEN Pharmaceuticals

HK$33.8

-1.51%

$-0.52

休場: Jan 16, 16:00:00 HKT

主要データ

前終値

$34.42

始値

$34.32

当日レンジ

$33.1 - $34.32

52週レンジ

$29.06 - $69.15

取引高

15.6K

平均取引高

32.8K

1株当たり利益(TTM)

-2.12

配当利回り

時価総額

$3.8B

VISEN PHARMA-Bとは何ですか？

VISEN Pharmaceuticals operates as a biopharmaceutical company. The company is headquartered in Suzhou, Jiangsu and currently employs 54 full-time employees. The company went IPO on 2025-03-21. The firm's main products under development include lonapegsomatropin, navepegritide, and palopegteriparatide. The lonapegsomatropin is used to treat growth hormone deficiency in children aged 3 to 17 years old. The navepegritide is a disease repair therapy used to treat children with cartilage dysplasia aged 2 to 10 years old. The palopegteriparatide is a treatment method used to treat adult hypoparathyroidism. The firm is in the late stage of research and development, and its products are close to commercialization.

特徴

取引戦略